Table 1 Baseline data for all the recruited subjects screened with T-SPOT.TB assay and TST
HIV+ATB | HIV+LTB | HIV only | |
|---|---|---|---|
Patient No. | 32 | 46 | 22 |
Age (years) median (SD) | 37.0 (8.6) | 33.9 (6.7) | 33.7 (5.8) |
Male/Female | 22/10 | 26/22 | 9/13 |
BCG vaccination history | Yes | Yes | Yes |
CD4+ T cell counts, n (%) | |||
<200/μl | 21 (65.6) | 4 (8.7) | 5 (22.7) |
200–500/μl | 10 (31.3) | 19 (41.3) | 9 (40.9) |
>500/μl | 1 (3.1) | 23 (50.0) | 8 (36.4) |
Anti-TB treatment, n (%) | |||
<1 mo | 18 (56.3) | No | No |
1–3 mo | 9 (28.1) | ||
>3 mo | 5 (15.6) | ||
HAART, n (%) | 20 (62.5) | 4 (8.7) | 2 (9.1) |